SATIV
DEAD

Serial Number

79276064

Owner

CNX THERAPEUTICS LIMITED

Attorney

MICHAEL T. OLSEN

Filing Date

Oct 3, 2019

Add to watchlist:

No watchlists yet
View on USPTO

SATIV Trademark

Serial Number: 79276064

SATIV is a trademark filed by CNX THERAPEUTICS LIMITED on October 3, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

CNX THERAPEUTICS LIMITED (3 trademarks)

3 BUNHILL ROW
LONDON EC1Y 8YZ , GB

Entity Type: 24

GW Pharma Limited (40 trademarks)

Sovereign House, Histon

Entity Type: 03

Jazz Pharmaceuticals Research UK Limited (46 trademarks)

Building 730,

Entity Type: 98

Trademark Details

Filing Date

October 3, 2019

Registration Date

Not Registered

Goods & Services

Pharmaceutical and veterinary preparations, namely, for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions, each of the foregoing for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pure extracts of medicinal plants and herbs for pharmaceutical use; foodstuffs for medicinal purposes; herb teas for medicinal purposes

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Mar 5, 2026 CHLD
CHANGE OF OWNER RECEIVED FROM IB
Feb 5, 2026 CHLD
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 18, 2025 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 13, 2024 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Jan 22, 2024 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 20, 2024 FICR
ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Jan 23, 2023 MAB3
ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Jan 20, 2023 MAB3
ABANDONMENT - AFTER EX PARTE APPEAL
Jan 17, 2023 ABN3
EXPARTE APPEAL TERMINATED
Jan 17, 2023 EXPT
EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Dec 5, 2022 EXFB
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Aug 17, 2022 GNS1
SUBSEQUENT FINAL EMAILED
Aug 17, 2022 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Aug 17, 2022 CFRC
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 6, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 5, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 5, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 3, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 3, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 3, 2022 CNRT
NEW REPRESENTATIVE AT IB RECEIVED
Nov 20, 2021 NREP
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 9, 2021 CRFA
ASSIGNED TO LIE
Nov 8, 2021 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 3, 2021 ERFR
EX PARTE APPEAL-INSTITUTED
Nov 3, 2021 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Nov 3, 2021 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Nov 3, 2021 EXAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 15, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 15, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 15, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 15, 2021 REAP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 27, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 9, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 9, 2021 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 3, 2021 GNFN
FINAL REFUSAL E-MAILED
May 3, 2021 GNFR
FINAL REFUSAL WRITTEN
May 3, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 27, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 26, 2021 TROA
REFUSAL PROCESSED BY IB
Oct 18, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 28, 2020 RFCS
REFUSAL PROCESSED BY MPU
Sep 28, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 5, 2020 RFCR
NON-FINAL ACTION WRITTEN
Sep 4, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 31, 2020 DOCK
ASSIGNED TO EXAMINER
Jan 16, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 14, 2020 MAFR
ASSIGNED TO EXAMINER
Jan 10, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 10, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 9, 2020 REPR